Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses

Vaccine

Volumn 26, Issue 23, 2008, Pages 2912-2918

  Du, Ning ^a   Li, Wei ^a   Li, Yuping ^b   Liu, Shanggao ^a   Sui, Yanping ^a   Qu, Zhe ^a   Wang, Yong ^a   Du, Yan ^a   Xu, Binrui ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Emergency measure; Potential influenza pandemic; Reassortant influenza A virus; Trivalent inactivated vaccine

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; SIALIDASE; TRIPLE VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENETIC REASSORTMENT; IMMUNOGENICITY; INFECTION CONTROL; INFLUENZA VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; VACCINES, INACTIVATED; VIRAL INTERFERENCE; VIRUS REPLICATION;

EID: 43349102550     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.048     Document Type: Article

References (31)

1. Swayne D.E., and Halvorson D.A. Influenza. In: Saif Y.M., Barnes H.J., Glisson J.R., Fadly A.M., McDougald L.R., and Swayne D.E. (Eds). Disease of poultry (2003), Iowa State University Press, Ames 135-160
2. Subbarao K., and Katz J.M. Avian influenza viruses infecting humans. Cell Mol Life Sci 57 (2000) 1770-1784
3. Lipatov A.S., Govorkova E.A., Webby R.J., Ozaki H., Peiris M., Guan Y., et al. Influenza: emergence and control. J Virol 78 (2004) 8951-8959
4. Saito T., Lim W., Suzuki T., Suzuki Y., Kida H., Nishimura S.I., et al. Characterization of a human H9N2 influenza virus isolated in Hong Kong. Vaccine 20 (2001) 125-133
5. Li H., Yu K., Yang H., Xin X., Chen J., Zhao P., et al. Isolation and characterization of H5N1 and H9N2 influenza viruses from pigs in China. Chin J Prev Vet Med (Chinese) 26 (2004) 1-6
6. Xu C.T., Fan W.X., Rong W., and Zhao H.K. Isolation and identification of swine influenza recombinant A/Swine/Shandong/1/2003(H9N2) virus. Microbes Infect 919-925 (2004) 6
7. Lin Y., Shaw M., Gregory V., Cameron K., Lim W., Klimov A., et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci USA 97 (2000) 9654-9658
8. Murphy B.R., Buckler-White A.J., London W.T., Harper J., Tierney E.L., and Miller N.T. Avian-Human reassortant influenza A viruses derived by mating avian and human influenza A viruses. J Infect Dis 150 (1984) 841-850
9. Sears S.D., Clements M.L., Betts R.F., Maassab H.F., Murphy B.R., and Snyder M.H. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and inactivated virus vaccine in adults. J Infect Dis (1988) 158
10. Shortridge K.F., and Stuart-Harris C.H. An influenza epicentre?. Lancet ii (1982) 212-213
11. Shu L.L., Lin Y.P., Wright S.M., Shortridge K.F., and Webster R.G. Evidence for interspecies transmission and reassortment of influenza A viruses in pigs in Southern China. Virology 202 (1994) 825-833
12. Nerome K., Kanegae Y., Shortridge K.F., Sugita S., and Ishida M. Genetic analysis of procine H3N2 viruses originating in Southern China. J Gen Virol (1995) 613-624
13. Brown L.H., Harris P.A., McCauley J.W., and Alexander D.J. Multiple genetic reassortant of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype. J Gen Virol 79 (1998) 2947-2955
14. Reeth K.V., Brown I.H., and Pensaert M. Isolation of H1N2 influenza A viruses from pigs in Belgium. Vet Rec 146 (2000) 588-589
15. Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erikson G., Rossow K., et al. Genetic reassortment of avian, swine and human influenza A viruses in American pigs. J Virol 73 (1999) 8851-8856
16. Stephenson I., Nicholson K.G., Wood J.M., Zambon M.C., and Katz J.M. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis 4 (2004) 499-509
17. Schwartz B., and Gellin B. Vaccination strategies for an influenza pandemic. J Infect Dis 191 (2005) 1207-1209
18. Katz J.M., Lim W., Brigdes C.B., Rowe T., Hu-Primmer J., Lu X., et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 180 (1999) 1763-1770
19. Lu X., Tumpey T.M., Morken T., Zake S.R., Cox N.J., and Katz J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 73 (1999) 5903-5911
20. Katz J.M., Lu X., Young S.A., and Galphin J.C. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J Infect Dis 175 (1997) 352-363
21. Ren G.F., Ruan W.Q., Li Q.G., Fan R.L., Chen C.R., and Gong X.C. Studies on reassortant influenza A viruses I: selection of high yielding and recombinant influenza A viruses with reassortant surface antigens (in Chinese, with English abstract). Acta Microbiol Sinica 20 (1980) 433-439
22. Kilbourne E.D. The influence of cortisone on experimental viral infection. IV. Negation of interference as the mechanism by which cortisone induces increased virus yields. J Exp Med 106 (1957) 863
23. Chen H., Subbarao K., Swayne D., Chen Q., Lu X., Katz J., et al. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine 21 (2003) 1974-1979
24. Cox N.J., and Kendal A.P. Genetic stability of A/Ann/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J Infect Dis 149 (1984) 194-200
25. Kistner O., Howard M.K., Spruth M., Wodal W., Bruhl P., Gerencer M., et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine 25 (2007) 6028-6036
26. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Sata T., Kurata T., et al. Protection against influenza B virus infection by immunization with DNA vaccines. Vaccine 19 (2001) 1446-1455
27. Li S.Q., Liu C.G., Klimov A., Subbarao K., Perdue M.L., Mo D., et al. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97(H5N1) viruses. J Infect Dis 179 (1999) 1132-1138
28. Liu Y., Ran D., and Cheng J. Researching progress of avian influenza vaccine. Avian Dis (Chinese) 2 (2008) 33-38
29. Riberdy J.M., Flynn K.J., Stech J., Webster R.G., Altman J.D., and Doherty P.C. Protection against a lethal avian influenza A virus in a mammalian system. J Virol 73 (1999) 1453-1459
30. Wen W., and Cheng X. Comparison on HI antibody level in chicken groups immunized by monovalent and divalent inactivated oil-emulsion vaccine of avian influenza. Henan Agric Sci (Chinese) 5 (2004) 66-68
31. Li M., Fan G., and Du Y. The experimental report on the bivalent oil emulsion inactivated avian influenza vaccine (H5 and H9 serotype). Chin J Anim Quarantine (in Chinese, with English abstract) 22 (2005) 25-27